Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis

Objective: Methotrexate (MTX) is a commonly used drug for the treatment of rheumatoid arthritis (RA) and it has been studied in RA resistance recently. P-glycoprotein (P-gp) is one of the important transporters that mediate MTX resistance. This study investigated the effect of Paeoniflorin-6′-O-benz...

Full description

Bibliographic Details
Main Authors: Hao Tang, Yi-jin Wu, Feng Xiao, Bin Wang, James Asenso, Yong Wang, Wei Sun, Chun Wang, Wei Wei
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332219334845
id doaj-3148c7ad09494d86ae87464795f43e99
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Hao Tang
Yi-jin Wu
Feng Xiao
Bin Wang
James Asenso
Yong Wang
Wei Sun
Chun Wang
Wei Wei
spellingShingle Hao Tang
Yi-jin Wu
Feng Xiao
Bin Wang
James Asenso
Yong Wang
Wei Sun
Chun Wang
Wei Wei
Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
Biomedicine & Pharmacotherapy
Methotrexate
P-glycoprotein
Paeoniflorin-6′-O-benzene sulfonate
Adjuvant arthritis
Resistance
author_facet Hao Tang
Yi-jin Wu
Feng Xiao
Bin Wang
James Asenso
Yong Wang
Wei Sun
Chun Wang
Wei Wei
author_sort Hao Tang
title Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
title_short Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
title_full Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
title_fullStr Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
title_full_unstemmed Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
title_sort regulation of cp-25 on p-glycoprotein in synoviocytes of rats with adjuvant arthritis
publisher Elsevier
series Biomedicine & Pharmacotherapy
issn 0753-3322
publishDate 2019-11-01
description Objective: Methotrexate (MTX) is a commonly used drug for the treatment of rheumatoid arthritis (RA) and it has been studied in RA resistance recently. P-glycoprotein (P-gp) is one of the important transporters that mediate MTX resistance. This study investigated the effect of Paeoniflorin-6′-O-benzene sulfonate (code: CP-25) in the resistance of P-gp-mediated MTX to RA. Methods: Adjuvant arthritis (AA) was induced in rats via complete Freund’s adjuvant. The experimental groups were divided into normal group; AA model group; monotherapy groups, including CP-25, MTX and dexamethasone; and CP-25 combined with MTX group. The expression of P-gp in synovial tissue was measured by western blot and histochemistry. Besides, P-gp high expression of human hepatoma cell line Bel7402/5-FU and Bel7402 were chose to study in MTX resistance and the function of P-gp was detected by Flow cytometry. Results: CP-25 had a good therapeutic effect on AA rats, significantly improved manifestations and reduced the expression of P-gp in synovial tissue, spleen medulla and small intestinal epithelial cells in the apical tissues of AA rats. In addition, CP-25 significantly inhibited the up-regulation of P-gp induced by TNF-α stimulation in synoviocytes. Furthermore, according to the accumulation and efflux of rhodamine 123 in Bel7402/5-FU resistant cells and Bel7402 sensitive cells, CP-25 could reverse the resistance of MTX in Bel7402/5-FU cells compared with Bel7402 cells, which was reflected by the reduced IC50 values of MTX. Further study indicated that CP-25 could decrease P-gp expression and inhibit P-gp function in Bel7402/5-FU cells. Conclusion: CP-25 regulates the expression of P-gp and inhibits the function of P-gp, thereby improving the resistance of MTX.
topic Methotrexate
P-glycoprotein
Paeoniflorin-6′-O-benzene sulfonate
Adjuvant arthritis
Resistance
url http://www.sciencedirect.com/science/article/pii/S0753332219334845
work_keys_str_mv AT haotang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT yijinwu regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT fengxiao regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT binwang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT jamesasenso regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT yongwang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT weisun regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT chunwang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
AT weiwei regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis
_version_ 1721435195715878912
spelling doaj-3148c7ad09494d86ae87464795f43e992021-05-20T07:39:02ZengElsevierBiomedicine & Pharmacotherapy0753-33222019-11-01119Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritisHao Tang0Yi-jin Wu1Feng Xiao2Bin Wang3James Asenso4Yong Wang5Wei Sun6Chun Wang7Wei Wei8Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China; Corresponding authors at: Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China.Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China; Corresponding authors at: Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China.Objective: Methotrexate (MTX) is a commonly used drug for the treatment of rheumatoid arthritis (RA) and it has been studied in RA resistance recently. P-glycoprotein (P-gp) is one of the important transporters that mediate MTX resistance. This study investigated the effect of Paeoniflorin-6′-O-benzene sulfonate (code: CP-25) in the resistance of P-gp-mediated MTX to RA. Methods: Adjuvant arthritis (AA) was induced in rats via complete Freund’s adjuvant. The experimental groups were divided into normal group; AA model group; monotherapy groups, including CP-25, MTX and dexamethasone; and CP-25 combined with MTX group. The expression of P-gp in synovial tissue was measured by western blot and histochemistry. Besides, P-gp high expression of human hepatoma cell line Bel7402/5-FU and Bel7402 were chose to study in MTX resistance and the function of P-gp was detected by Flow cytometry. Results: CP-25 had a good therapeutic effect on AA rats, significantly improved manifestations and reduced the expression of P-gp in synovial tissue, spleen medulla and small intestinal epithelial cells in the apical tissues of AA rats. In addition, CP-25 significantly inhibited the up-regulation of P-gp induced by TNF-α stimulation in synoviocytes. Furthermore, according to the accumulation and efflux of rhodamine 123 in Bel7402/5-FU resistant cells and Bel7402 sensitive cells, CP-25 could reverse the resistance of MTX in Bel7402/5-FU cells compared with Bel7402 cells, which was reflected by the reduced IC50 values of MTX. Further study indicated that CP-25 could decrease P-gp expression and inhibit P-gp function in Bel7402/5-FU cells. Conclusion: CP-25 regulates the expression of P-gp and inhibits the function of P-gp, thereby improving the resistance of MTX.http://www.sciencedirect.com/science/article/pii/S0753332219334845MethotrexateP-glycoproteinPaeoniflorin-6′-O-benzene sulfonateAdjuvant arthritisResistance